PTPN2 and neoplasm: In MC38 tumor-bearing mice, the PTPN2/PTP1B inhibitor ABBV-CLS-484 shows dose-dependent immune activation and reversible immune infiltration of in vivo tissues that is dependent on its administration status [105].